Lumio, Norwalito B.

HRN: 19-02-75  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/03/2025
CEFTAZIDIME 1GM (VIAL)
05/03/2025
05/17/2025
IV
1 Gram
Q8
Ptb Va Cap Mr
Waiting Final Action 
05/18/2025
CEFTAZIDIME 1GM (VIAL)
05/18/2025
05/25/2025
IV
1g
Q8
CAP MR
Waiting Final Action 
05/19/2025
CLARITHROMYCIN 500MG (CAP)
05/19/2025
05/25/2025
PO
500mg
BID
CAP MR
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: